Send to

Choose Destination
Sci Rep. 2013 Nov 20;3:3273. doi: 10.1038/srep03273.

Oral 'hydrogen water' induces neuroprotective ghrelin secretion in mice.

Author information

1] Department of Pharmacology, Graduate School of Medicine, Chiba University, Chiba [2] Division of Molecular Design, Medical Institute of Bioregulation, Kyushu University, Fukuoka [3] Research Center for Nucleotide Pool, Kyushu University, Fukuoka, Japan [4].


The therapeutic potential of molecular hydrogen (H₂) is emerging in a number of human diseases and in their animal models, including in particular Parkinson's disease (PD). H₂ supplementation of drinking water has been shown to exert disease-modifying effects in PD patients and neuroprotective effects in experimental PD model mice. However, H₂ supplementation does not result in detectable changes in striatal H₂ levels, indicating an indirect effect. Here we show that H₂ supplementation increases gastric expression of mRNA encoding ghrelin, a growth hormone secretagogue, and ghrelin secretion, which are antagonized by the β1-adrenoceptor blocker, atenolol. Strikingly, the neuroprotective effect of H₂ water was abolished by either administration of the ghrelin receptor-antagonist, D-Lys(3) GHRP-6, or atenolol. Thus, the neuroprotective effect of H₂ in PD is mediated by enhanced production of ghrelin. Our findings point to potential, novel strategies for ameliorating pathophysiology in which a protective effect of H₂ supplementation has been demonstrated.

[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center